News

Scatec Sells African Hydropower Assets to TotalEnergies in Major Deal

Scatec Sells African Hydropower Assets to TotalEnergies in Major Deal

Scatec Finalizes Major Sale to TotalEnergies

In a significant move, Scatec ASA has successfully closed the sale of its 51% stake in an African hydropower joint venture to TotalEnergies, marking a noteworthy shift in its strategic approach. The transaction was valued at USD 167 million, a figure determined based on an evaluation dated December 31, 2023.

Estimating net proceeds at approximately USD 161 million after adjusting for cash fluctuations between the valuation and finalization dates, Scatec plans to utilize these funds for its self-sustained growth initiatives and to facilitate additional corporate debt repayments.

Details of the Hydropower Assets

The agreement encompasses critical operating assets, including the 255 MW Bujagali hydropower plant located in Uganda, alongside a promising development pipeline featuring the 361 MW Mpatamanga project in Malawi and the 206 MW Ruzizi III plant straddling the borders of Rwanda, the Democratic Republic of the Congo, and Burundi.

Furthermore, the transition involves the Hydro Africa team, which will shift to TotalEnergies under the newly incorporated structure of SN Power AS. This strategic move is designed to streamline operations and enhance focus on renewable energy initiatives.

Investment Strategy and Future Directions

“We are truly pleased to announce the completion of this transaction,” remarked Scatec’s CEO, Terje Pilskog. He emphasized that this divestment aligns with the company's overarching goal to optimize its asset portfolio, concentrating investments primarily on solar, onshore wind, and battery energy storage solutions.

With the expectation that TotalEnergies will be a robust steward of these hydropower assets, Pilskog extended his gratitude to the hydropower team for their unwavering dedication throughout the years.

Financial Implications and Accounting Effects

The recent transaction is projected to result in a notable accounting impact. Scatec is set to recognize a total proportionate accounting effect of approximately USD 30 million along with a consolidated accounting effect of about USD 50 million. These figures will predominantly stem from foreign currency fluctuations and will be acknowledged in the company’s financial reports for the first quarter of the following year.

Company Overview and Future Commitments

Scatec is recognized as a frontrunner in renewable energy solutions, committed to expanding access to reliable and affordable clean energy in emerging markets. With a robust portfolio of 4.8 GW in operation and under construction across five continents, Scatec remains dedicated to enhancing its renewable energy capacity. The company thrives on the aspirations and dedication of its employees and partners, all aligned with the vision of ‘Improving our Future’.

Headquartered in Oslo, Norway, and publicly traded on the Oslo Stock Exchange under the ticker symbol ‘SCATC’, Scatec continues to pave the way for sustainable energy innovations worldwide.

The information regarding the sale of these assets illustrates not only Scatec's strategic moves but also its commitment to strengthening its overall position in the renewable energy market.

Frequently Asked Questions

What was the total value of the sale of Scatec's hydropower assets?

The sale was valued at USD 167 million.

What will the proceeds from the sale be used for?

The proceeds will support Scatec's self-funded growth plan and facilitate additional debt repayments.

Which hydropower plants were included in the sale?

The sale included the 255 MW Bujagali plant in Uganda, the 361 MW Mpatamanga in Malawi, and the 206 MW Ruzizi III plant.

Who will take over the Hydro Africa team?

The Hydro Africa team will be transferred to TotalEnergies in an entity known as SN Power AS.

What is Scatec’s primary focus after this sale?

After this sale, Scatec aims to concentrate investments in solar, onshore wind, and battery energy storage.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles